Vaidya Sane Ayurved Laboratories Past Earnings Performance
Past criteria checks 4/6
Vaidya Sane Ayurved Laboratories has been growing earnings at an average annual rate of 21.7%, while the Healthcare industry saw earnings growing at 22.7% annually. Revenues have been declining at an average rate of 14% per year. Vaidya Sane Ayurved Laboratories's return on equity is 6.9%, and it has net margins of 4.5%.
Key information
21.7%
Earnings growth rate
22.9%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | -14.0% |
| Return on equity | 6.9% |
| Net Margin | 4.5% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Investors Aren't Entirely Convinced By Vaidya Sane Ayurved Laboratories Limited's (NSE:MADHAVBAUG) Revenues
Nov 08
Should You Be Adding Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) To Your Watchlist Today?
Aug 25Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable
Jun 11Revenue & Expenses Breakdown
How Vaidya Sane Ayurved Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 900 | 41 | 427 | 0 |
| 30 Jun 24 | 947 | 30 | 442 | 0 |
| 31 Mar 24 | 993 | 20 | 458 | 0 |
| 31 Dec 23 | 1,020 | 26 | 454 | 0 |
| 30 Sep 23 | 1,047 | 33 | 450 | 0 |
| 30 Jun 23 | 1,019 | 41 | 437 | 0 |
| 31 Mar 23 | 992 | 48 | 423 | 0 |
| 31 Dec 22 | 940 | 48 | 336 | 0 |
| 30 Sep 22 | 887 | 48 | 248 | 0 |
| 30 Jun 22 | 817 | 42 | 258 | 0 |
| 31 Mar 22 | 747 | 35 | 268 | 0 |
| 31 Mar 21 | 523 | 4 | 166 | 0 |
| 31 Mar 20 | 752 | -6 | 371 | 0 |
| 31 Mar 19 | 625 | 5 | 307 | 0 |
| 31 Mar 18 | 376 | 11 | 166 | 0 |
Quality Earnings: MADHAVBAUG has high quality earnings.
Growing Profit Margin: MADHAVBAUG's current net profit margins (4.5%) are higher than last year (3.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MADHAVBAUG has become profitable over the past 5 years, growing earnings by 21.7% per year.
Accelerating Growth: MADHAVBAUG's earnings growth over the past year (23.6%) exceeds its 5-year average (21.7% per year).
Earnings vs Industry: MADHAVBAUG earnings growth over the past year (23.6%) did not outperform the Healthcare industry 29.6%.
Return on Equity
High ROE: MADHAVBAUG's Return on Equity (6.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 17:07 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vaidya Sane Ayurved Laboratories Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|